Renaissance Technologies
ASTH icon

Renaissance Technologies’s Astrana Health ASTH Stock Holding History

Renaissance Technologies’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.46M Sell
74,646
-29,900
-29% -$1.08M ﹤0.01% 1653
2026
Q1 		$2.56M Buy
104,546
+11,400
+12% +$270K ﹤0.01% 1745
2025
Q4 		$2.31M Buy
93,146
+10,346
+12% +$275K ﹤0.01% 1774
2025
Q3 		$2.35M Sell
82,800
-12,800
-13% -$347K ﹤0.01% 1964
2025
Q2 		$2.38M Sell
95,600
-93,100
-49% -$2.62M ﹤0.01% 2011
2025
Q1 		$5.85M Sell
188,700
-29,200
-13% -$973K 0.01% 1337
2024
Q4 		$6.87M Buy
217,900
+149,300
+218% +$7.09M 0.01% 1239
2024
Q3 		$3.97M Buy
68,600
+19,400
+39% +$953K 0.01% 1591
2024
Q2 		$2M Buy
49,200
+16,700
+51% +$662K ﹤0.01% 1890
2024
Q1 		$1.36M Buy
32,500
+8,700
+37% +$339K ﹤0.01% 2281
2023
Q4 		$912K Buy
23,800
+16,100
+209% +$536K ﹤0.01% 2467
2023
Q3 		$238K Buy
+7,700
New +$266K ﹤0.01% 3030
2023
Q2 		– Sell
-40,475
Closed -$1.48M – 4327
2023
Q1 		$1.48M Sell
40,475
-25,225
-38% -$883K ﹤0.01% 2215
2022
Q4 		$1.94M Buy
+65,700
New +$2.11M ﹤0.01% 2087
2021
Q4 		– Sell
-4,300
Closed -$392K – 4281
2021
Q3 		$392K Sell
4,300
-54,400
-93% -$4.63M ﹤0.01% 2981
2021
Q2 		$3.69M Buy
58,700
+10,800
+23% +$399K ﹤0.01% 1825
2021
Q1 		$1.3M Sell
47,900
-8,500
-15% -$204K ﹤0.01% 2484
2020
Q4 		$1.03M Buy
+56,400
New +$1.01M ﹤0.01% 2483

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies's ASTH Position: Q2 2026 in Review

Renaissance Technologies reduced its Astrana Health (ASTH) stake by 29% in Q2 2026, selling an estimated $1.08M and leaving 74,646 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1653.

Renaissance Technologies first reported a position in ASTH in Q4 2020 and has held it in 18 quarters since. The position peaked at $6.87M in Q4 2024. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Renaissance Technologies held 74,646 shares of Astrana Health worth $3.46M as of Q2 2026.
  • Renaissance Technologies sold 29,900 Astrana Health shares in Q2 2026, an estimated $1.08M.
  • Astrana Health made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1653 holding.
  • Renaissance Technologies first reported a position in Astrana Health in Q4 2020 and has held it in 18 quarters since.
  • Renaissance Technologies's Astrana Health position peaked at $6.87M in Q4 2024.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.